Citigroup’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.2K | Buy |
1,631
+1,115
| +216% | +$20.6K | ﹤0.01% | 4656 |
|
|
2025
Q4 | $7.08K | Sell |
516
-1,483
| -74% | -$23.1K | ﹤0.01% | 5158 |
|
|
2025
Q3 | $35.4K | Sell |
1,999
-5,301
| -73% | -$83.9K | ﹤0.01% | 4600 |
|
|
2025
Q2 | $110K | Sell |
7,300
-6,547
| -47% | -$109K | ﹤0.01% | 4357 |
|
|
2025
Q1 | $223K | Sell |
13,847
-1,744
| -11% | -$32.5K | ﹤0.01% | 4144 |
|
|
2024
Q4 | $271K | Buy |
15,591
+2,379
| +18% | +$41.9K | ﹤0.01% | 4219 |
|
|
2024
Q3 | $232K | Buy |
13,212
+9,224
| +231% | +$157K | ﹤0.01% | 4243 |
|
|
2024
Q2 | $44.6K | Buy |
3,988
+1,048
| +36% | +$9.87K | ﹤0.01% | 4655 |
|
|
2024
Q1 | $25.6K | Buy |
2,940
+615
| +26% | +$5.65K | ﹤0.01% | 4953 |
|
|
2023
Q4 | $28.5K | Buy |
2,325
+2,318
| +33,114% | +$16.1K | ﹤0.01% | 4836 |
|
|
2023
Q3 | $28 | Sell |
7
-4,803
| -100% | -$29.8K | ﹤0.01% | 5571 |
|
|
2023
Q2 | $34.6K | Buy |
+4,810
| New | +$30.7K | ﹤0.01% | 4808 |
|
|
2022
Q4 | – | Sell |
-4,500
| Closed | -$10K | – | 5914 |
|
|
2022
Q3 | $10K | Buy |
4,500
+4,376
| +3,529% | +$7.11K | ﹤0.01% | 4998 |
|
|
2022
Q2 | $0 | Sell |
124
-377
| -75% | -$948 | ﹤0.01% | 6558 |
|
|
2022
Q1 | $2K | Sell |
501
-3,166
| -86% | -$25.9K | ﹤0.01% | 6083 |
|
|
2021
Q4 | $54K | Buy |
3,667
+1,970
| +116% | +$39.2K | ﹤0.01% | 5024 |
|
|
2021
Q3 | $36K | Buy |
1,697
+994
| +141% | +$21.4K | ﹤0.01% | 4925 |
|
|
2021
Q2 | $11K | Sell |
703
-280
| -28% | -$5.33K | ﹤0.01% | 5627 |
|
|
2021
Q1 | $23K | Sell |
983
-1,713
| -64% | -$51.2K | ﹤0.01% | 5169 |
|
|
2020
Q4 | $64K | Buy |
2,696
+2,017
| +297% | +$32.1K | ﹤0.01% | 5873 |
|
|
2020
Q3 | $8K | Sell |
679
-1,271
| -65% | -$13.7K | ﹤0.01% | 6769 |
|
|
2020
Q2 | $20K | Sell |
1,950
-1,372
| -41% | -$12.4K | ﹤0.01% | 6617 |
|
|
2020
Q1 | $24K | Buy |
3,322
+1,068
| +47% | +$11.1K | ﹤0.01% | 6572 |
|
|
2019
Q4 | $30K | Buy |
2,254
+774
| +52% | +$11K | ﹤0.01% | 6717 |
|
|
2019
Q3 | $23K | Sell |
1,480
-131
| -8% | -$1.7K | ﹤0.01% | 6656 |
|
|
2019
Q2 | $21K | Buy |
1,611
+412
| +34% | +$5.62K | ﹤0.01% | 7063 |
|
|
2019
Q1 | $21K | Buy |
1,199
+1
| +0.1% | +$16 | ﹤0.01% | 6931 |
|
|
2018
Q4 | $14K | Buy |
1,198
+1,188
| +11,880% | +$14.4K | ﹤0.01% | 7039 |
|
|
2018
Q3 | $0 | Buy |
+10
| New | +$142 | ﹤0.01% | 7839 |
|
|
2018
Q2 | – | Sell |
-44
| Closed | -$1K | – | 7699 |
|
|
2018
Q1 | $1K | Sell |
44
-102
| -70% | -$1.94K | ﹤0.01% | 7465 |
|
|
2017
Q4 | $3K | Buy |
+146
| New | +$3.45K | ﹤0.01% | 7337 |
|
|
2017
Q3 | – | Sell |
-61
| Closed | -$2K | – | 7399 |
|
|
2017
Q2 | $2K | Buy |
+61
| New | +$1.68K | ﹤0.01% | 7009 |
|
Other funds holding PLSE
VCM
PCM
GAM
LP
Citigroup's PLSE Position: Q1 2026 in Review
Citigroup increased its Pulse Biosciences (PLSE) stake by 216% in Q1 2026, buying an estimated $20.6K and bringing the position to 1,631 shares worth $35.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4656.
Citigroup first reported a position in PLSE in Q2 2017 and has held it in 32 quarters since. The position peaked at $271K in Q4 2024. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- Citigroup held 1,631 shares of Pulse Biosciences worth $35.2K as of Q1 2026.
- Citigroup bought 1,115 Pulse Biosciences shares in Q1 2026, an estimated $20.6K.
- Pulse Biosciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4656 holding.
- Citigroup first reported a position in Pulse Biosciences in Q2 2017 and has held it in 32 quarters since.
- Citigroup's Pulse Biosciences position peaked at $271K in Q4 2024.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.